Skip to main content
. 2012 Oct 23;79(17):1809–1816. doi: 10.1212/WNL.0b013e3182704056

Table 3.

Progression to AD-type dementia and rate of cognitive decline with respect to biomarker status at baselinea

graphic file with name znl04112-0450-t03.jpg

Abbreviations: AD = Alzheimer disease; CI = confidence interval; HR = hazard ratio; MMSE = Mini-Mental State Examination; p-tau = tau phosphorylated at threonine 181; t-tau = total tau.

a

Dementia-free survival and the HR were calculated using Cox regression analyses with correction for age, gender, and educational level. Baseline MMSE scores and slope values of annual change in MMSE score were estimated using mixed models with correction for age, gender, educational level, and center. Values are estimated assuming that subjects are 50% female, are 70 years of age, and have 11 years of education.

b

Abnormal CSF t-tau was defined as a value ≥375 pg/mL; hippocampal atrophy was defined as a volume of both left and right hippocampus of <5.39 cm3.

c

Differences in baseline MMSE between the groups were not statistically significant.

d

The p value compared with both markers normal = 0.1.

e

The p value compared with both markers normal = 0.02.